TY - JOUR
T1 - A post-pandemic snapshot of the magnitude of COVID-19 in Brazil
T2 - A countrywide study
AU - Kohn, Eduardo Ribes
AU - Bohlke, Maristela
AU - Almeida, Antônia
AU - Janelli, Leandro
AU - Sardinha, Luciana Monteiro Vasconcelos
AU - Wehrmeister, Fernando C.
AU - Hallal, Pedro Curi
N1 - We want to thank everyone involved in the Covitel study and our partners Associa\u00E7\u00E3o Umane (coordination and financing), Instituto Ibirapitanga (co-financing), Universidade Federal de Pelotas (UFPel), and Vital Strategies Brazil.
PY - 2025/1/1
Y1 - 2025/1/1
N2 - Objective: To outline the features of COVID-19 in Brazil through a countrywide telephone survey. Methods: Data from the Telephone Survey of Risk Factors for Chronic Noncommunicable Diseases During the Pandemic (Covitel), a telephone survey of individuals aged 18 years or older from all macro-regions of Brazil, were used. The questionnaire included sociodemographic characteristics and outcomes related to COVID-19 infection, severity, vaccination, and use of masks. Results: Data revealed that 34.7 % (95 %CI 32.4 – 37.1) of the population had been diagnosed with COVID-19, and 10.1 % (95 %CI 7.9 – 12.7) of those required hospital admission. The prevalence of COVID-19 diagnosis increased with education level: <8 years (26.6 % [95 %CI 23.1 – 30.7]), 9–11 years (33.4 % [95 %CI 29.4 – 37.7]), and >11 years (53.2 % [95 % CI 49.7 – 56.8]). Nevertheless, the hospitalization rate of Brazilians with more than eleven years of education was lower (5.8 % [95 %CI 4.3 – 7.6]). In 2023, 92.9 % (95 %CI 90.9 – 94.4) of the Brazilian population was fully vaccinated against COVID-19, but only 37.2 % (95 %CI 33.5 – 40.9) have received the updated vaccinal scheme (two doses and two boosters). During the pandemic outbreak, 81.9 % (95 %CI 79.4 – 84.2) reported always using face masks. However, only 16.1 % (95 %CI 13.5 – 19.0) maintained this practice in 2023. Conclusion: There were inequalities in COVID-19 testing in Brazil. Testing and vaccination policies implemented in the COVID-19 pandemic must be reevaluated by the Brazilian government.
AB - Objective: To outline the features of COVID-19 in Brazil through a countrywide telephone survey. Methods: Data from the Telephone Survey of Risk Factors for Chronic Noncommunicable Diseases During the Pandemic (Covitel), a telephone survey of individuals aged 18 years or older from all macro-regions of Brazil, were used. The questionnaire included sociodemographic characteristics and outcomes related to COVID-19 infection, severity, vaccination, and use of masks. Results: Data revealed that 34.7 % (95 %CI 32.4 – 37.1) of the population had been diagnosed with COVID-19, and 10.1 % (95 %CI 7.9 – 12.7) of those required hospital admission. The prevalence of COVID-19 diagnosis increased with education level: <8 years (26.6 % [95 %CI 23.1 – 30.7]), 9–11 years (33.4 % [95 %CI 29.4 – 37.7]), and >11 years (53.2 % [95 % CI 49.7 – 56.8]). Nevertheless, the hospitalization rate of Brazilians with more than eleven years of education was lower (5.8 % [95 %CI 4.3 – 7.6]). In 2023, 92.9 % (95 %CI 90.9 – 94.4) of the Brazilian population was fully vaccinated against COVID-19, but only 37.2 % (95 %CI 33.5 – 40.9) have received the updated vaccinal scheme (two doses and two boosters). During the pandemic outbreak, 81.9 % (95 %CI 79.4 – 84.2) reported always using face masks. However, only 16.1 % (95 %CI 13.5 – 19.0) maintained this practice in 2023. Conclusion: There were inequalities in COVID-19 testing in Brazil. Testing and vaccination policies implemented in the COVID-19 pandemic must be reevaluated by the Brazilian government.
KW - Adults
KW - Brazil
KW - COVID-19
KW - Long COVID
UR - http://www.scopus.com/inward/record.url?scp=85212631140&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85212631140&partnerID=8YFLogxK
U2 - 10.1016/j.bjid.2024.104496
DO - 10.1016/j.bjid.2024.104496
M3 - Article
C2 - 39709886
AN - SCOPUS:85212631140
SN - 1413-8670
VL - 29
JO - Brazilian Journal of Infectious Diseases
JF - Brazilian Journal of Infectious Diseases
IS - 1
M1 - 104496
ER -